Protective Effect of Metformin Against Cisplatin-Induced Ototoxicity in an Auditory Cell Line
- 3 December 2013
- journal article
- Published by Springer Nature in Journal of the Association for Research in Otolaryngology
- Vol. 15 (2) , 149-158
Abstract
Metformin, an antidiabetic drug with potent anticancer activity, is known to prevent oxidative stress-induced cell death in several cell types through a mechanism dependent on the mitochondria. In the present study, we investigated the influence of metformin on cisplatin ototoxicity in an auditory cell line. Cell viability was determined using a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide (Sigma, St. Louis, MO, USA) cell proliferation assay. Oxidative stress and apoptosis were assessed by flow cytometry analysis, Hoechst 33258 staining, reactive oxygen species (ROS) measurement, and western blotting. Intracellular calcium concentration changes were detected using calcium imaging. Pretreatment with 1 mM metformin prior to the application of 20 μM cisplatin significantly decreased the frequency of late apoptosis in HEI-OC1 cells and also significantly attenuated the cisplatin-induced increase in ROS. In addition, metformin inhibited the activation of caspase-3 and levels of poly-ADP-ribose polymerase (PARP). Pretreatment with metformin prevented the cisplatin-induced elevation in intracellular calcium concentrations. We propose that metformin protects against cisplatin-induced ototoxicity by inhibiting the increase in intracellular calcium levels, preventing apoptosis, and limiting ROS production.Keywords
This publication has 39 references indexed in Scilit:
- Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neuronsBMC Neuroscience, 2012
- Protective role of antidiabetic drug metformin against gentamicin induced apoptosis in auditory cell lineHearing Research, 2011
- Protection of pancreatic INS-1 β-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metforminCell Death & Disease, 2011
- Metformin: A Therapeutic Opportunity in Breast CancerClinical Cancer Research, 2010
- Cisplatin-Induced OtotoxicityOtology & Neurotology, 2008
- Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamineExperimental & Molecular Medicine, 2007
- Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro studyBiochemical Journal, 2004
- Mechanisms of Apoptosis Induced by Cisplatin in Marginal Cells in Mouse Stria VascularisORL, 2004
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Comparative Adverse Effect Profiles of Platinum DrugsDrug Safety, 1995